195 related articles for article (PubMed ID: 15342014)
1. The genetics of HLA-associated disease.
Larsen CE; Alper CA
Curr Opin Immunol; 2004 Oct; 16(5):660-7. PubMed ID: 15342014
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation within the major histocompatibility complex subregion centromeric of HLA class II in type 1 diabetes.
van der Slik AR; van den Eng I; Eerligh P; Doxiadis II; Koeleman BP; Roep BO; Giphart MJ
Tissue Antigens; 2007 Apr; 69(4):348-53. PubMed ID: 17389020
[TBL] [Abstract][Full Text] [Related]
3. The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1.
Husain Z; Kelly MA; Eisenbarth GS; Pugliese A; Awdeh ZL; Larsen CE; Alper CA
J Autoimmun; 2008 Jun; 30(4):266-72. PubMed ID: 18065200
[TBL] [Abstract][Full Text] [Related]
4. MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis.
Alizadeh BZ; Eerligh P; van der Slik AR; Shastry A; Zhernakova A; Valdigem G; Bruining JG; Sanjeevi CB; Wijmenga C; Roep BO; Koeleman BP
Mol Immunol; 2007 Apr; 44(11):2806-12. PubMed ID: 17350686
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA genes in families with autoimmune diabetes and thyroiditis.
Levin L; Ban Y; Concepcion E; Davies TF; Greenberg DA; Tomer Y
Hum Immunol; 2004 Jun; 65(6):640-7. PubMed ID: 15219384
[TBL] [Abstract][Full Text] [Related]
6. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex.
Aly TA; Baschal EE; Jahromi MM; Fernando MS; Babu SR; Fingerlin TE; Kretowski A; Erlich HA; Fain PR; Rewers MJ; Eisenbarth GS
Diabetes; 2008 Mar; 57(3):770-6. PubMed ID: 18065518
[TBL] [Abstract][Full Text] [Related]
7. HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example.
Gorodezky C; Alaez C; Murguía A; Rodríguez A; Balladares S; Vazquez M; Flores H; Robles C
Autoimmun Rev; 2006 Mar; 5(3):187-94. PubMed ID: 16483918
[TBL] [Abstract][Full Text] [Related]
8. Conserved, extended MHC haplotypes.
Alper CA; Awdeh Z; Yunis EJ
Exp Clin Immunogenet; 1992; 9(2):58-71. PubMed ID: 1489551
[TBL] [Abstract][Full Text] [Related]
9. Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility.
Shin HD; Yang SW; Kim DH; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():76-85. PubMed ID: 19120272
[TBL] [Abstract][Full Text] [Related]
10. STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes.
Lee HS; Park H; Yang S; Kim D; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():93-8. PubMed ID: 19120275
[TBL] [Abstract][Full Text] [Related]
11. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.
Morahan G; Huang D; Ymer SI; Cancilla MR; Stephen K; Dabadghao P; Werther G; Tait BD; Harrison LC; Colman PG
Nat Genet; 2001 Feb; 27(2):218-21. PubMed ID: 11175794
[TBL] [Abstract][Full Text] [Related]
12. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
13. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
[TBL] [Abstract][Full Text] [Related]
14. Genetic determinants of type 1 diabetes across populations.
Jahromi MM; Eisenbarth GS
Ann N Y Acad Sci; 2006 Oct; 1079():289-99. PubMed ID: 17130568
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the risk of type 1 diabetes from polymorphisms in candidate genes.
Park Y
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S19-25. PubMed ID: 15563974
[TBL] [Abstract][Full Text] [Related]
16. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.
Viken MK; Blomhoff A; Olsson M; Akselsen HE; Pociot F; Nerup J; Kockum I; Cambon-Thomsen A; Thorsby E; Undlien DE; Lie BA
Genes Immun; 2009 Jun; 10(4):323-33. PubMed ID: 19295542
[TBL] [Abstract][Full Text] [Related]
17. 14th International HLA and Immunogenetics Workshop: report on the HLA component of type 1 diabetes.
Steenkiste A; Valdes AM; Feolo M; Hoffman D; Concannon P; Noble J; Schoch G; Hansen J; Helmberg W; Dorman JS; Thomson G; Pugliese A;
Tissue Antigens; 2007 Apr; 69 Suppl 1():214-25. PubMed ID: 17445204
[TBL] [Abstract][Full Text] [Related]
18. Localization of Type 1 Diabetes susceptibility in the ancestral haplotype 18.2 by high density SNP mapping.
Santiago JL; Li W; Lee A; Martinez A; Chandrasekaran A; Fernandez-Arquero M; Khalili H; de la Concha EG; Urcelay E; Gregersen PK
Genomics; 2009 Oct; 94(4):228-32. PubMed ID: 19591919
[TBL] [Abstract][Full Text] [Related]
19. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
[TBL] [Abstract][Full Text] [Related]
20. From genome to aetiology in a multifactorial disease, type 1 diabetes.
Todd JA
Bioessays; 1999 Feb; 21(2):164-74. PubMed ID: 10193189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
